Source-grounded facts extracted from INSULET CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
INSULET CORP shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“Ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026”
INSULET CORP shareholders approved Advisory approval of executive compensation (Say-on-Pay) at the 2026-05-20 meeting.
“Provided advisory approval of the compensation of certain of the Company’s executive officers (“Say-on-Pay”)”
INSULET CORP shareholders approved Election of three Class I directors at the 2026-05-20 meeting.
“Elected each of the three Class I director nominees to the Board for a three-year term”
INSULET CORP: Board approved amendment and restatement of bylaws to designate exclusive forum for certain actions, including Delaware Chancery Court for derivative/breach of fiduciary duty claims and federal district courts for Securities Act claims, effective immediately (effective 2026-05-20).
“On May 20, 2026, the Board of Directors of Insulet Corporation (the “ Company ”) approved the amendment and restatement of the Company’s Bylaws (the “ Amended Bylaws ”), effective immediately, to designate the Court of Chancery of the State of Delaware (or if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if such state court lacks subject matter jurisdiction, the federal district court within the State of Delaware) as the sole and exclusive forum for certain actions including derivative actions or proceedings brought on behalf of the Company and actions for breach of fiduciary duty owed by any of the Company’s officers or directors. Further, the Amended Bylaws designate the federal district courts of the United States as the sole and exclusive forum for any action asserting a claim arising under the U.S. Securities Act of 1933, as amended.”
INSULET CORP reported first quarter ended March 31, 2026 results: revenue $761.7 million, net income $91.1 million, or $1.30 per diluted share, EPS $1.30 per diluted share. Guidance raised.
“with its Omnipod ® brand of products, today announced its financial results for the three months ended March 31, 2026. First Quarter Financial Highlights: • Revenue of $761.7 million, up 33.9%, or 30.1% in constant currency 1 , and exceeded the high end of the Company’s guidance range of 25% - 27% at constant currency rates ◦ Total Omnipod revenue of $758.4”
INSULET CORP engaged PwC as its auditor.
“the Audit Committee selected PwC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.”
INSULET CORP dismissed GT as its auditor.
“GT was dismissed as the Company’s independent registered public accounting firm upon completion of its audit services on February 18, 2026.”
INSULET CORP amended 2026 Addendum with NXP USA, Inc. (effective 2026-01-01).
“On January 29, 2026, Insulet Corporation (the “ Company ”) and NXP USA, Inc. (“ NXP ”) entered into an Addendum effective January 1, 2026 (the “ 2026 Addendum”) to the Purchase Agreement, dated as of October 12, 2017, between the Company and NXP (the “ Original Agreement ”), as amended.”
INSULET CORP dismissed Grant Thornton LLP as its auditor.
“poration (the “Company”) approved the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm, subject to completion of standard client acceptance procedures, and dismissed Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
INSULET CORP engaged PricewaterhouseCoopers LLP as its auditor.
“s Certifying Accountant On December 15, 2025, following careful deliberation and a competitive process, the Audit Committee (the “Committee”) of the Board of Directors of Insulet Corporation (the “Company”) approved the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm, subject to completion of standard client acceptance procedures, and dismissed Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Grant Thornton was previously engaged to audit the Company’s consolidated financial statements for the year ending December 31, 2025. The appointment of PwC does not affect Grant Thornton’s engagement for the year ended December 31, 2025. Grant Thornton’s reports on the consolidated financial statements of the Company for the fiscal years”
INSULET CORP incurred credit facility of $481,250,000 with Morgan Stanley Senior Funding, Inc. at 1.00%, in the case of base rate loans, and 2.00%, in the case of term SOFR loans.
“and as amended by the Amendment, the “ Amended Credit Agreement ”), by and among the Company, the lenders and other parties thereto and the Agent. Pursuant to the Amendment, the $481,250,000 in aggregate principal amount of term loans outstanding under the Credit Agreement (the “ Existing Term Loans ”) were replaced with an equal amount of new term loans (the “ New”
James R. Hollingshead resigned as ceo at INSULET CORP.
“James R. Hollingshead, who has agreed with the Board that his employment will cease effective as of April 28, 2025, and resigned from the Board.”
Ashley McEvoy was appointed as President and Chief Executive Officer at INSULET CORP.
“the Board appointed Ashley McEvoy as President and Chief Executive Officer of the Company and as a member of the Board as a Class III Director.”
Mark Field departed as Senior Vice President and Chief Technology Officer at INSULET CORP.
“Mark Field, who had been serving as the Company’s Senior Vice President and Chief Technology Officer, left the Company, effective March 14, 2025.”
INSULET CORP amended revolving credit of $500 million aggregate amount of New Revolving Commitments, undrawn as of Closing Date with Morgan Stanley Senior Funding, Inc., as administrative agent, and the lenders at Adjusted Term SOFR plus applicable margin (2.00%-2.50%) or base rate plus applic maturing March 20, 2030.
“Revolving Commitments”). After giving effect to such transactions, on the Closing Date, the aggregate amount of New Revolving Commitments under the Amended Credit Agreement is $500 million (the “Revolving Credit Facility”), which commitments were undrawn as of such date. Proceeds of loans borrowed and letters of credit issued under the Revolving Credit Facility”
INSULET CORP incurred senior notes of $450 million aggregate principal amount with Initial purchasers at 6.50% per annum maturing April 1, 2033.
“On March 20, 2025 (the “Closing Date”), Insulet Corporation (the “Company”) closed its previously announced issuance and sale of $450 million aggregate principal amount of the Company’s 6.50% Senior Notes due 2033 (the “Notes”).”
Amit Guliani was appointed as acting Chief Technology Officer at INSULET CORP.
“Amit Guliani, currently serving as Group Vice President, Software Engineering, will serve as acting Chief Technology Officer, effective immediately.”
Mark Field departed as Chief Technology Officer at INSULET CORP.
“Mark Field, Senior Vice President, Chief Technology Officer of Insulet Corporation (the “ Company ”) left the Company to pursue other opportunities, effective March 14, 2025.”
INSULET CORP updated its Full Year 2024 guidance (raised).
“Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year Raising Full Year Revenue and Operating Margin Guidance”
INSULET CORP reported first quarter ended March 31, 2024 results: revenue 441.7 million, net income 51.5 million, EPS 0.73. Guidance raised.
“First quarter 2024 revenue of $441.7 million, up 23.3%, or 22.8% in constant currency 1 , compared to $358.1 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency due to revenue outperformance for all product lines”
Lauren Budden departed as Interim CFO and Treasurer at INSULET CORP.
“Lauren Budden, who has been serving as the Company’s Interim CFO and Treasurer, will step down as Interim CFO and Treasurer and continue in her role as Group Vice President, Chief Accounting Officer and Controller.”
Ana Maria Chadwick was appointed as Executive Vice President, Chief Financial Officer and Treasurer at INSULET CORP.
“On March 20, 2024, Insulet Corporation (the “ Company ”) announced the appointment, effective April 22, 2024, of Ana Maria Chadwick to serve as Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer.”
INSULET CORP reported financial results for the three months and full year ended December 31, 2023.
“On February 22, 2024, Insulet Corporation (the “Company”) announced its financial results for the fourth quarter and year ended December 31, 2023.”
INSULET CORP amended credit facility of $487,500,000 term loans outstanding replaced with equal amount of new term loans with Morgan Stanley Senior Funding, Inc. at interest rate margin reduced from 2.25% to 2.00% for base rate loans and from 3. maturing maturity unchanged.
“and as amended by the Amendment, the “ Amended Credit Agreement ”), by and among the Company, the lenders and other parties thereto and the Agent. Pursuant to the Amendment, the $487,500,000.00 in aggregate principal amount of term loans outstanding under the Credit Agreement (the “ Existing Term Loans ”) were replaced with an equal amount of new term loans (the “ New”
INSULET CORP amended Fifth Amendment to Credit Agreement with Morgan Stanley Senior Funding, Inc., as administrative agent, and the lenders and other parties thereto valued at $487,500,000.00 (effective 2024-01-24).
“On January 24, 2024, Insulet Corporation (the " Company ") entered into the Fifth Amendment to Credit Agreement (the " Amendment ") with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent”
Corinne H. Nevinny retired as Director at INSULET CORP.
“In addition, on January 17, 2024, Corinne H. Nevinny notified the Company of her decision to step down from the Board, effective as of the Company’s 2024 Annual Meeting of Stockholders.”
Shacey Petrovic retired as Director at INSULET CORP.
“On January 17, 2024, Shacey Petrovic, a member of the Company’s Board of Directors, notified the Company of her decision not to stand for re-election to the Board at the Company’s 2024 Annual Meeting of Stockholders.”
Tim Stonesifer was appointed as Director at INSULET CORP.
“On January 18, 2024, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Flavia Pease and Tim Stonesifer as Class II and Class I directors, respectively, effective January 18, 2024.”
Flavia Pease was appointed as Director at INSULET CORP.
“On January 18, 2024, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Flavia Pease and Tim Stonesifer as Class II and Class I directors, respectively, effective January 18, 2024.”
INSULET CORP reported the three months ended September 30, 2023 results: revenue $432.7 million, net income $51.9 million, EPS $0.74 per diluted share. Guidance raised.
“Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2023. Third Quarter Financial Highlights: • Third quarter 2023 revenue of $432.7 million, up 27.0%, or 25.1% in constant currency 1 , compared to $340.8 million in the prior year ◦ Total Omnipod revenue of $422.0 million, an increase of 29.4%, or 27.5% in constant”
Lauren Budden was appointed as Interim Chief Financial Officer and Treasurer at INSULET CORP.
“The Company’s Chief Accounting Officer and Controller, Lauren Budden, 48, will serve as Interim Chief Financial Officer (“ CFO ”) and Treasurer, effective upon Mr. McMillan’s departure.”
Wayde McMillan resigned as Executive Vice President, Chief Financial Officer and Treasurer at INSULET CORP.
“On September 29, 2023, Wayde McMillan, the Executive Vice President, Chief Financial Officer and Treasurer of Insulet Corporation (the “ Company ”) informed the Company of his decision to resign from such position, effective October 20, 2023.”
INSULET CORP amended revolving credit of $300 million with Morgan Stanley Senior Funding, Inc. (as administrative agent) at adjusted Term SOFR rate plus an applicable margin of 3.25% maturing June 9, 2028.
“Commitments ”). After giving effect to such extension and increase, on the Closing Date, the aggregate amount of New Revolving Commitments under the Credit Agreement is $300 million (the “ Revolving Credit Facility ”), which commitments were undrawn as of such date. Proceeds of loans borrowed and letters of credit issued under the Revolving Credit Facility”
INSULET CORP amended Fourth Amendment to Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $200 million (effective 2023-06-09).
“On June 9, 2023 (the “ Closing Date ”), Insulet Corporation (the “ Company ”) entered into the Fourth Amendment to Credit Agreement (the “ Amendment ”) among the Company, the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”), swingline lender, and letter of credit issuer, amending that certain Credit Agreement, dated as of May 4, 2021”
INSULET CORP amended Amendment Number 21 with Amgen Inc. (effective 2023-06-01).
“On June 1, 2023, Insulet Corporation (the “ Company ”) and Amgen Inc. (“ Amgen ”) entered into Amendment Number 21 (“ Amendment 21 ”) to the Supply Agreement, dated as of November 21, 2013, between the Company and Amgen, as amended by Amendments 1-20, pursuant to which Insulet manufactures and sells to Amgen customized devices (the “ Original Agreement ”).”
INSULET CORP shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-05-23 meeting.
“Proposal 4. Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. For Against Abstentions Broker Non-Votes 66,392,146 30,474 10,331 1,642,287”
INSULET CORP shareholders approved Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation at the 2023-05-23 meeting.
“Proposal 3. Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation 1 Year 2 Year 3 Year Abstentions 64,450,157 8,477 322,633 9,397”
INSULET CORP shareholders approved Advisory Vote on Executive Compensation – Say on Pay at the 2023-05-23 meeting.
“Proposal 2. Advisory Vote on Executive Compensation – Say on Pay For Against Abstentions Broker Non-Votes 63,337,095 1,400,733 52,836 1,642,287”
INSULET CORP shareholders approved Election of Directors at the 2023-05-23 meeting.
“Proposal 1. Election of Directors Nominee For Withheld Broker Non-Votes Luciana Borio 61,057,108 3,733,556 1,642,287 Michael R. Minogue 60,247,889 4,542,775 1,642,287 Corinne H. Nevinny 59,376,392 5,414,272 1,642,287”
Bret Christensen departed as Executive Vice President, Chief Commercial Officer at INSULET CORP.
“Bret Christensen, Executive Vice President, Chief Commercial Officer of the Company will be leaving the Company, effective May 5, 2023, in connection with an internal reorganization”
INSULET CORP reported first quarter ended March 31, 2023 results: revenue $358.1 million, net income $23.8 million, EPS $0.34 per diluted share.
“First Quarter Financial Highlights: • First quarter 2023 revenue of $358.1 million, up 21.2%, or 23.3% in constant currency 1 , compared to $295.4 million in the prior year ◦ Total Omnipod revenue of $357.6 million, an increase of 32.7%, or 34.9% in constant currency ◦ U.S. Omnipod revenue of $259.0 million, an increase of 48.8% ◦ International Omnipod revenue of $98.6 million, an increase of 3.4%, or an increase of 9.6% in constant currency ◦ Drug Delivery revenue of $0.5 million, a decrease of 98.1% • Gross margin of 67.2%, down 380 basis points. Adjusted gross margin 1 of 64.9% excludes income of $8.0 million associated with the voluntary medical device correction (MDC) notices issued in 2022 • Operating income of $27.7 million, or 7.7% of revenue, compared to $37.9 million, or 12.8% of revenue, in the prior year. Adjusted operating income 1 of $19.7 million, or 5.5%, excludes income of $8.0 million noted above • Net income of $23.8 million, or $0.34 per diluted share, compared to $”
INSULET CORP reported Fourth Quarter 2022 results: revenue $369.7 million.
“Fourth quarter 2022 revenue of $369.7 million, up 20.1%, or 23.7% in constant currency, compared to $307.7 million in the prior year”
INSULET CORP reported Full Year 2022 results: revenue $1.3 billion, net income $4.6 million, EPS $0.07 per diluted share.
“Full year 2022 revenue of $1.3 billion, up 18.8%, or 22.5% in constant currency, compared to $1.1 billion in the prior year, exceeds the guidance range of 18% to 19% in constant currency”
INSULET CORP reported the fourth quarter ended December 31, 2022 results: revenue $369.7 million.
“Fourth quarter 2022 revenue of $369.7 million, up 20.1%, or 22.6% in constant currency, compared to $307.7 million in the prior year, exceeds the guidance range of 11% to 14% in constant currency”
INSULET CORP reported the full year ended December 31, 2022 results: revenue $1.3 billion, net income $4.6 million, EPS $0.07 per diluted share.
“Full year 2022 revenue of $1.3 billion, up 18.8%, or 22.2% in constant currency, compared to $1.1 billion in the prior year, exceeds the guidance range of 18% to 19% in constant currency ◦ Total Omnipod revenue of $1.2 billion, an increase of 23.4%, or 27.0% in constant currency ◦ U.S. Omnipod revenue of $884.8 million, an increase of 35.8% ◦ International Omnipod revenue of $363.0 million, an increase of 0.9%, or 12.1% in constant currency ◦ Drug Delivery revenue of $57.5 million, a decrease of 34.2% • Gross margin of 61.7%, down 670 basis points. Adjusted gross margin 1 of 66.2% excludes a charge of $57.9 million associated with the voluntary medical device correction (MDC) notices issued to replace Omnipod DASH ® Personal Diabetes Managers (PDMs) and Omnipod ® 5 Automated Insulin Delivery system (Omnipod 5) Controllers • Operating income of $37.6 million, or 2.9% of revenue, compared to $126.0 million, or 11.5% of revenue, in the prior year. Adjusted operating income 1 of $124.1 mil”
INSULET CORP entered into Patent Assignment and License Agreement with Bigfoot Biomedical, Inc. and Patients Pending, Ltd. (collectively, "Bigfoot") (effective 2023-02-09).
“On February 9, 2023, Insulet Corporation (the “Company”) entered into a Patent Assignment and License Agreement with Bigfoot Biomedical, Inc. and Patients Pending, Ltd. (collectively, “Bigfoot”) pursuant to which the Company acquired from Bigfoot approximately 400 patents as well as a significant number of patent applications, and licensed a significant number of additional patents and patent applications on a fully paid-up exclusive or non-exclusive basis.”
Prem Singh was appointed as Senior Vice President, Global Operations at INSULET CORP.
“The Company has appointed Prem Singh as Senior Vice President, Global Operations, effective January 1, 2023.”
Charles Alpuche retired as Executive Vice President, Chief Operating Officer at INSULET CORP.
“Charles Alpuche, the Executive Vice President, Chief Operating Officer of Insulet Corporation (the “Company”) informed the Company of his decision to retire from this position, effective December 31, 2022.”
INSULET CORP amended revolving credit of $100 million with Morgan Stanley Senior Funding, Inc..
“The Third Amendment increased the revolving credit commitments thereunder by $30 million. After giving effect to such increase, on the Closing Date, the aggregate amount of revolving credit commitments under the Credit Agreement was $100 million, which commitments were undrawn as of such date.”
INSULET CORP amended Third Amendment to Credit Agreement with the lenders and the Agent valued at $30 million (effective 2022-11-30).
“(the “ Closing Date ”), Insulet Corporation (the “ Company ”) entered into (a) the Second Amendment to Credit Agreement (the “ Second Amendment ”) between the Company and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”) and (b) the Third Amendment to Credit Agreement (the “ Third Amendment ”) among the Company, the lenders and other parties thereto and the Agent, in each case amending that certain Credit Agreement, dated as of May 4, 2021 (as previously amended, supplemented or modified, the “ Credit Agreement ”), by and among the Company, the lenders and other parties thereto and the Agent.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.